Legal aspects of chronic opioid therapy

Current Pain and Headache Reports

Volumn 10, Issue 6, 2006, Pages 426-430

  Chan, Kwai Tung ^c   Fishman, Scott M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ellison Ambulatory Care Center   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ANALGESIA; CONFUSION; DRUG ABUSE; DRUG LEGISLATION; DRUG USE; GOVERNMENT; HEALTH CARE POLICY; LAW ENFORCEMENT; LEGAL ASPECT; LONG TERM CARE; MEDICAL SOCIETY; PAIN; PHYSICIAN; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; REVIEW; TRUST; UNITED STATES;

ANALGESICS, OPIOID; DRUG AND NARCOTIC CONTROL; HUMANS; PAIN; UNITED STATES;

EID: 33751332557     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-006-0073-4     Document Type: Review

References (32)

1. Heit HA: The truth about pain management: the difference between a pain patient and an addicted patient. Eur J Pain 2001, 5(Suppl A):27-29.
2. Fishman SM, Papazian JS, Gonzalez S, et al.: Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain. Pain Med 2004, 5:309-324.
3. Dilcher AJ: Damned if they do, damned if they don't: the need for a comprehensive public policy to address the inadequate management of pain. Ann Health Law 2004, 13:81-144.
4. Controlled Substances Act. Title 21 USC 801 (1). http://www.deadiversion.usdoj.gov/21cfr/21usc/801.htm. Accessed September 12, 2006.
5. Controlled Substances Act. Title 21 USC 823 (a) (1). http://www.deadiversion.usdoj.gov/21cfr/21usc/21icusct.htm. Accessed September 12, 2006.
6. Code of Federal Regulations. Title 21 CFR 1306.07(c). http://www.access.gpo.gov/nara/cfr/waisidx_03/21cfr13O6_O3.html. Accessed September 12, 2006.
7. Joranson DE, Gilson Am, Ryan KM, et al.: Achieving Balance in State Pain Policy: A Guide to Evaluation. Edited by The Pain and Rolicy Studies Group. Madison, WI: University of Wisconsin Comprehensive Cancer Center; 2000.
8. Drug Enforcement Administration, Last Acts, Pain and Policy Studies Group, American Hospice and Palliative Medicine, American Academy of Pain Medicine, American Alliance of Cancer Pain Initiatives. Promoting pain relief and preventing abuse of pain medications: a critical balancing act. http://www.medsch.wisc.edu/painpolicy/dea01.htm. Accessed April 4, 2006
9. Prescription Pain Medications: Frequently Asked Questions and Answers for Health Care Professionals and Law Enforcement Personnel. http://www.painmed.org/about/academy/pdfs/PainMedFAQ.pdf Accessed April 4, 2006.
10. Heit HA: Healthcare professionals and the DEA: trying to get back in balance. Pain Med 2006, 7:72-74.
11. Bolen J: DEA and Schedule II "do not fill prescriptions" disappointing enforcement activity. Pain Med 2006, 7:80-85.
12. Heit HA, Covington E, Good PM: Dear DEA. Pain Med 2004, 5:303-308.
13. Interim Policy Statement. Fed Regist 2004, 69:67170-67172.
14. DEA Clarification Statement. Fed Regist 2005, 70:50408-50409.
15. Fishman SM: Pain and politics: DEA, Congress, and the courts, oh my! Pain Med 2006, 7:87-88.
16. Gilson AM, Maurer MA, Joranson DE: State policy affecting pain management: recent improvements and the positive impact of regulatory health policies. Health Policy 2005, 74:192-204.
17. Simoni-Wastilia L, Tompkins C: Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential. Subt Use Misuse 2001, 36:1275-1296.
18. Kasprak J: State Programs for Electronic Monitoring of Controlled Substance Prescriptions. Connecticut General Assembly OLR Research Report. Hartford, CT: 2003.
19. The Federation of State Medical Boards of the United States, Inc.: Model policy for the use of controlled substances for the treatment of pain. http://www.fsmb.org. Accessed March 10, 2006.
20. Public policy statement on the rights and responsibilities of health care professionals in the use of opioids for the treatment of pain: a consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. Pain Med 2004, 5:301-3012.
21. American Academy of Pain Medicine: The use of opioids for the treatment of chronic pain. http://www.painmed.org/productpub/statements/pdfs/ opioids.pdf. Accessed September 12, 2006.
22. Gilson AM, Ryan KM, Joranson DE et al.: A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage 2004, 28:176-188.
23. Overview of findings from the 2004 National Survey on Drug Use and Health. http://oas.samhsa.gov/NSDUH/2k4NSDUH/2k4Overview/ 2k4Overview.pdf. Accessed September 12, 2006.
24. Drug Abuse Warning Network, 2003: Interim National Estimates of Drug-related Emergency Department Visits. http://dawninfo.samhsa.gov/ files/DAWN_ED_Interim2OO3.pdf. Accessed September 12, 2006.
25. The President's National Drug Control Policy February 2006. http://www.whitehousedrugpolicy.gov/publications/policy/ndcs06/ disrupt_mkt.html. Accessed September 12, 2006.
26. Joranson DE, Gilson AM: Drug crime is a source of abused pain medications in the United States. J Pain Symptom Manage 2005, 30:299-301.
27. Fishman SM: Commentary to MS 04-169. From balanced pain care to drug trafficking: the case of Dr. William Hurwitz and the DEA. Pain Med 2005, 6:161-164.
28. Richard J, Reidenberg MM: Findings on the risk of disciplinary action by state medical boards against physicians prescribing opioids. J Pain Symptom Manage 2005, 29:206-212.
29. Johnson SH: Providing relief to those in pain: a retrospective on the scholarship and impact of the Mayday Project. J Law Med Ethics 2003, 31:15-20.
30. Fishman SM: The debate on elder abuse for undertreated pain. Pain Med 2004, 5:212-213.
31. Tucker KL: Medico-legal case report and commentary: inadequate pain management in the context of terminal cancer. The case of Lester Tomlinson. Pain Med 2004, 5:214-228.
32. Fishman SM: The politics of pain and its impact on pain medicine. Pain Med 2005, 6:199-200.